Founder & CEO of Gousto | Automated Recipe Box Unicorn
“Data science and automation can make fresh home cooking more sustainable and affordable.”
— Timo BoldtHeavy-industry engineer conquering atomic manufacturing, localized supply chains, and complex physical-world engineering.
Timo Boldt founded Gousto in 2012, pioneering algorithmically planned meal subscriptions. By engineering automated robotic fulfillment centres in the UK, Gousto delivers fresh ingredients with near-zero inventory food waste.
Gousto is a British meal kit company that delivers pre-portioned ingredients and chef-crafted recipes using proprietary automated fulfillment systems.
Original founder video breakdowns, keynote presentations, and interviews documenting company growth and industry transformation.
Strategic ecosystem bets, enterprise divisions, and high-conviction ventures expanding the founder's industrial footprint.
Timo Boldt is a United Kingdom entrepreneur and Founder & CEO of Gousto | Automated Recipe Box Unicorn based in London, United Kingdom. They are widely celebrated as the primary builder behind Gousto.
Timo Boldt's exact personal net worth is privately held and not publicly disclosed. Their primary financial value is tied to their equity in Gousto.
Timo Boldt embodies the The Industrial Titan archetype on Limitless Founders, characterized by high-conviction decision-making, operational discipline, and relentless execution across pivotal markets.
Timo Boldt has deployed strategic angel capital into early-stage market challengers, with verified portfolio bets including FoodTech.
Timo Boldt advocates for first-principles rigor, summarized by their defining thesis: "Data science and automation can make fresh home cooking more sustainable and affordable."
Directly researching and publishing definitive chronicles on the architects of tomorrow.
View Author Profile →Claim this verified profile to update milestones or feature your latest ventures.
Claim ProfileBuilders across diverse sectors who share the exact same psychological drive, risk calculus, and operational DNA.
